TechnipFMC plc Ordinary Share vs Revvity Inc — how do they compare? TechnipFMC plc Ordinary Share trades at $69.99 (market cap $27.31B), while Revvity Inc trades at $152.05 (market cap $16.98B). The key difference: TechnipFMC plc Ordinary Share is the larger of the two by market cap, and TechnipFMC plc Ordinary Share pays the higher dividend (0.29%). Which is the better fit depends on your goals — on Pluang, investors hold TechnipFMC plc Ordinary Share for 0 Days and Revvity Inc for 12 Days on average.
| FTI | RVTY | |
|---|---|---|
Market Cap | $27.31B | $16.98B |
Volume | 2,496,410 | 1,456,900 |
Sector | Energy | Health |
52-Week High | $80.08 | $157.36 |
52-Week Low | $35.57 | $82.26 |
Typical Hold Time | 0 Days | 12 Days |
Enterprise Value | $27.56B | $19.30B |
Dividend Yield | 0.29% | 0.18% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
RVTY trades at $153.60, up 0.2% today and near its 52-week high of $158.28 (Defense World, 2026-10-01). The stock shows a bullish technical trend with strong moving average signals and has beaten earnings estimates for three consecutive quarters. Recent developments include the launch of a CE-IVDR-certified T1D screening kit in Europe (Business Wire, 2026-09-24) and the acquisition of Human Cell Design to expand metabolic disease research tools (Business Wire, 2026-09-09).
The outlook is positive, supported by earnings momentum, strategic acquisitions, and analyst optimism. However, the stock trades at a premium valuation with a P/E of 73.15, and near-term risks include margin pressures in China and rich valuation limiting upside beyond consensus targets. Revenue stability but slight profit margin compression in 2026 warrants monitoring.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
TechnipFMC is an energy technology company providing subsea systems, surface technologies, and related services across the life of oil and gas fields. Its offerings include equipment, controls, installation support, and digital tools for offshore and onshore projects.
Read more on FTI →Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →